LIANTONIO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 7.436
AS - Asia 3.282
EU - Europa 2.467
SA - Sud America 818
AF - Africa 119
OC - Oceania 5
Totale 14.127
Nazione #
US - Stati Uniti d'America 7.308
SG - Singapore 1.378
IT - Italia 821
CN - Cina 742
BR - Brasile 664
HK - Hong Kong 408
SE - Svezia 291
RU - Federazione Russa 255
DE - Germania 229
VN - Vietnam 218
FR - Francia 207
FI - Finlandia 175
UA - Ucraina 168
GB - Regno Unito 138
IN - India 102
BD - Bangladesh 99
CA - Canada 65
ID - Indonesia 65
AR - Argentina 50
BE - Belgio 38
TR - Turchia 35
MX - Messico 33
IQ - Iraq 32
ZA - Sudafrica 31
NL - Olanda 29
SA - Arabia Saudita 25
EC - Ecuador 24
PK - Pakistan 24
JP - Giappone 23
CI - Costa d'Avorio 21
VE - Venezuela 21
PL - Polonia 19
UZ - Uzbekistan 18
CL - Cile 17
CO - Colombia 16
CZ - Repubblica Ceca 16
ES - Italia 15
MA - Marocco 15
IE - Irlanda 12
PH - Filippine 11
IR - Iran 10
LT - Lituania 10
NP - Nepal 10
PY - Paraguay 10
TN - Tunisia 10
EG - Egitto 9
KE - Kenya 9
MY - Malesia 9
AE - Emirati Arabi Uniti 7
AT - Austria 7
CR - Costa Rica 7
PE - Perù 7
ET - Etiopia 6
IL - Israele 6
JO - Giordania 6
KR - Corea 6
KZ - Kazakistan 6
TW - Taiwan 6
DZ - Algeria 5
KG - Kirghizistan 5
PA - Panama 5
PS - Palestinian Territory 5
UY - Uruguay 5
AL - Albania 4
AU - Australia 4
BO - Bolivia 4
CH - Svizzera 4
OM - Oman 4
RO - Romania 4
TH - Thailandia 4
AM - Armenia 3
DK - Danimarca 3
GE - Georgia 3
LB - Libano 3
LV - Lettonia 3
NI - Nicaragua 3
RS - Serbia 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
DM - Dominica 2
EE - Estonia 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
NG - Nigeria 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CY - Cipro 1
GM - Gambi 1
GP - Guadalupe 1
GR - Grecia 1
LK - Sri Lanka 1
Totale 14.113
Città #
Singapore 767
Fairfield 739
Ashburn 695
Woodbridge 567
Chandler 439
San Jose 425
Hong Kong 406
Houston 390
Jacksonville 379
Cambridge 316
Milan 295
Seattle 292
Dallas 282
Nyköping 247
Wilmington 241
Ann Arbor 232
Beijing 193
Bari 119
Lauterbourg 118
Lawrence 104
New York 104
Roxbury 103
Los Angeles 99
Nanjing 89
Rome 88
Princeton 82
Ho Chi Minh City 67
Des Moines 65
Helsinki 62
Inglewood 60
Boardman 58
Council Bluffs 58
São Paulo 54
Santa Clara 51
Jakarta 44
Hanoi 43
Munich 39
Brussels 37
Buffalo 37
Jiaxing 36
San Diego 36
Columbus 33
Nanchang 32
Falkenstein 29
Dong Ket 27
Hebei 27
Shenyang 27
Chicago 24
London 24
Brooklyn 23
Rio de Janeiro 22
Toronto 22
Abidjan 21
Frankfurt am Main 21
The Dalles 21
Tokyo 21
Turku 21
Falls Church 20
Moscow 20
Brasília 18
Montreal 18
Nuremberg 18
Johannesburg 17
Shanghai 17
Warsaw 17
Belo Horizonte 16
Changsha 16
Dearborn 16
Guangzhou 16
Paris 16
Atlanta 15
Brno 15
Orem 15
Tashkent 15
Baghdad 14
Dhaka 14
Phoenix 14
Pune 14
Chennai 13
Mexico City 13
Biên Hòa 12
Denver 12
Dublin 12
Jeddah 12
San Mateo 12
Figino 11
Haiphong 11
Taranto 11
Tianjin 11
Augusta 10
Manchester 10
Stockholm 10
Washington 10
Zhengzhou 10
Genova 9
Guayaquil 9
Hefei 9
Istanbul 9
Monmouth Junction 9
Poplar 9
Totale 9.528
Nome #
Effects of Nandrolone in the counteraction of skeletal muscle atrophy in a mouse model of muscle disuse: molecular biology and functional evaluation 246
ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force 227
Antioxidant treatment of hindlimb-unloaded mouse counteracts fiber type transition but not atrophy of disused muscles 206
Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin 206
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 202
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia 202
Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options 201
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy. 194
On the metabolically active form of metaglidasen: improved synthesis and investigation of its peculiar activity on peroxisome proliferator-activated receptors and skeletal muscles 189
Activation and inhibition of kidney CLC-K chloride channels by fenamates 186
Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine 183
Ion channels in drug discovery and safety pharmacology 183
Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse 169
Carboxylic acids and skeletal muscle chloride channel conductance: Effects on the biological activity induced by the introduction of an aryloxyalkyl group α to the carboxylic function of 4-chloro-phenoxyacetic acid 156
A multidisciplinary evaluation of the effectiveness of cyclosporine A in dystrophic mdx mice 154
Alteration of stim1/orai1-mediated soce in skeletal muscle: Impact in genetic muscle diseases and beyond 148
Paracrine Effects of IGF-1 Overexpression on the Functional Decline Due to Skeletal Muscle Disuse: Molecular and Functional Evaluation in Hindlimb Unloaded MLC/mIgf-1 Transgenic Mice 144
Pre-clinical trials in Duchenne dystrophy: what animal models can tell us about potential drug effectiveness 142
Phosphorylation and IGF-1-mediated dephosphorylation pathways control the activity and the pharmacological properties of skeletal muscle chloride channels 141
Fiber type-related changes in rat skeletal muscle calcium homeostasis during aging and restoration by growth hormone 140
Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT1 receptor blockers valsartan and olmesartan 139
Antioxidant treatment of hindlimb-unloaded mouse in vivo counteracts fiber type transition but not atrophy of disused skeletal muscles 138
Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies 137
Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives 135
Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery 135
Calcium homeostasis is altered in skeletal muscle of spontaneously hypertensive rats cytofluorimetric and gene expression analysis 134
Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1 134
Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1 132
Statins and fenofibrate affect skeletal muscle chloride conductance in rats by different impairing ClC-1 channel regulation and expression 131
Recovery of the soleus muscle after short- and long-term disuse induced by hindlimb unloading: effects on the electrical properties and myosin heavy chain profile 129
New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse 128
Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders 128
Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium 127
Effect of HMG-CoA reductase inhibitors on excitation-contraction coupling of rat skeletal muscle 126
Peptidic and Nonpeptidic Growth Hormone Secretagogues exert a protective effect on mitochondrial parameters analysed in a rat model of cachexia 126
Protein kinase C theta (PKCθ) modulates the ClC-1 chloride channel activity and skeletal muscle phenotype: a biophysical and gene expression study in mouse models lacking the PKCθ 126
Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels 124
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 123
The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo 121
A novel kcna2 variant in a patient with non-progressive congenital ataxia and epilepsy: Functional characterization and sensitivity to 4-aminopyridine 121
In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: A new drug target for hypertension? 120
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 119
Taurine and skeletal muscle ion channels 119
Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle 119
Age-dependent effects of disuse on electrophysiogical parameters and calcium homeostasis in the soleus muscle of hindlimb-unloaded mice 118
Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms. 117
Effects of Pleiotrophin Overexpression on Mouse Skeletal Muscles in Normal Loading and in Actual and Simulated Microgravity 117
Taurine and skeletal muscle disorders 116
Functional Study of Novel Bartter's Syndrome Mutations in ClC-Kb and Rescue by the Accessory Subunit Barttin Toward Personalized Medicine 116
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 114
Block of renal CLC-K channels by phenoxy-alkyl derivatives of clofibric acid 114
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 111
Kv1.1 channelopathies: Pathophysiological mechanisms and therapeutic approaches 110
Pharmacology of CLC chloride channels and transporters 108
An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function 108
Involvement of Barttin Subunit in Pharmacological Potentiation of CLC-K Channels Expressed in Xenopus Oocytes 107
Effect of rat hindlimb suspension on cable properties, ionic conductances and fiber type composition of slow-twitch muscle. 106
Molecular determinants of differential pore blocking of kidney CLC-K chloride channels 105
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/non-peptidyl structure 105
Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers 104
Protein Kinase C-Theta Controls the CLC-1 Chloride Channel Function and Skeletal Muscle Phenotype: A Biophysical and Gene Expression Study in Pkc-Theta Null Mice 103
I-J loop involvement in the pharmacological profile of CLC-K channels expressed in Xenopus oocytes 103
Disuse of rat muscle in vivo reduces protein kinase C activity controlling the sarcolemma chloride conductance 102
Paving the way for Bartter syndrome type 3 drug discovery: a hope from basic research 102
Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome 101
Investigating a Benzofurane Derivative Binding Site on Human CLC-5 101
Potential benefits of taurine in the prevention of skeletal muscle impairment induced by disuse in the hindlimb-unloaded rat 100
Molecular determinants of 2(p-chlorophenoxy)propionic acid for modulation of the native chloride channel conductance of rat skeletal muscle 100
null 100
Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia 99
Mechanisms of block of muscle type CLC chloride channels 99
Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes 99
Comparison of excitability parameters and sodium channel behavior of fast- and slow-twitch rat skeletal muscles for the study of the effects of hindlimb suspension, a model of hypogravity. 97
Taurine and skeletal muscle ion channels 97
An olive oil–derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function 97
Branched-chain amino acids and L-alanine supplementation ameliorate calcium dyshomeostasis in sarcopenia: New insights for nutritional interventions 95
Therapeutic approaches to ion channel diseases 95
Potential targets for skeletal muscle impairment by hypogravity: basic characterization of resting ionic conductances and mechanical threshold of rat fast- and slow-twitch muscle fibers 93
null 93
null 90
The Biallelic Inheritance of Two Novel SCN1A Variants Results in Developmental and Epileptic Encephalopathy Responsive to Levetiracetam 89
Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid 89
Potent and stereoselective use-dependent block of skeletal muscle Na+ channels by a new proline-like tocainide derivative 88
Mechanism of Interaction of Niflumic Acid with Heterologously Expressed Kidney CLC-K Chloride Channels 88
null 87
Decrease in resting calcium and calcium entry associated with slow-to-fast transition in unloaded rat soleus muscle 86
Molecular switch for CLC-K Cl– channel block/activation: Optimal pharmacophoric requirements towards high-affinity ligands 86
Therapeutic Approaches to Tuberous Sclerosis Complex: From Available Therapies to Promising Drug Targets 85
Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase. 85
Brugada Syndrome: More than a Monogenic Channelopathy 85
Mechanism of block of single protopores of the Torpedo chloride channel ClC-0 by 2-(p-chlorophenoxy)butyric acid (CPB) 84
Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications 83
Sarcoplasmic Reticulum Ca2+ Buffer Proteins: A Focus on the Yet-To-Be-Explored Role of Sarcalumenin in Skeletal Muscle Health and Disease 83
Taurine ameliorates in vitro and in vivo the electrical and contractile properties of skeletal muscle fibres of dystrophic mdx mouse 81
Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: Outcome of a large array of in vivo and ex vivo tests 81
Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach 80
Pleiotropic Effects of Direct Oral Anticoagulants in Chronic Heart Failure and Atrial Fibrillation: Machine Learning Analysis 79
Potent effect of chiral derivative of mexiletine on rat skeletal muscle sodium channel 78
Effects of sacubitril-valsartan on aging-related cardiac dysfunction 77
Biophysical Aspects of Neurodegenerative and Neurodevelopmental Disorders Involving Endo-/Lysosomal CLC Cl-/H+ Antiporters 76
Totale 12.102
Categoria #
all - tutte 60.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.483


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022867 42 143 10 32 42 63 48 37 56 57 131 206
2022/20231.252 200 113 93 91 125 186 13 147 192 17 36 39
2023/2024494 31 79 26 64 50 106 24 20 5 36 7 46
2024/20252.293 81 37 153 75 77 225 226 216 89 123 301 690
2025/20265.163 655 252 457 495 549 243 614 149 572 480 197 500
2026/2027133 133 0 0 0 0 0 0 0 0 0 0 0
Totale 14.525